Impact of Attention on Obsessive Thoughts Through THOUGHT
Launched by ASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS · Jul 5, 2023
Trial Information
Current as of July 09, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called "Impact of Attention on Obsessive Thoughts Through THOUGHT," is studying how attention affects obsessive thoughts in people with Obsessive Compulsive Disorder (OCD) as well as those without the condition. The researchers are using a special tool called the THOUGHT-scale to look at the types of thoughts people have and how much attention those thoughts require in different situations. The goal is to better understand OCD and improve treatments for those who struggle with it.
To participate in this trial, you need to be over 15 years old and either have OCD or be someone without the condition. If you have OCD, you can join if you are being treated at Albert Chenevier Hospital. For those without OCD, participation is available if you are consulting or being admitted to GH Henri Mondor. It's important to note that individuals with certain mental health conditions, like schizophrenia or bipolar disorder, cannot participate. Participants can expect to share their experiences and thoughts in a supportive environment, helping researchers learn more about how attention influences obsessive thinking.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- For pathological patients:
- • Over the age of 15
- • Suffering from OCD (obsessive compulsive disorder)
- • All comorbidities are possible except schizophrenia, bipolarity and anorexia nervosa
- • Consultant or admitted to Albert Chenevier Hospital
- For patients who are not affected by the disease:
- • Over 15 years of age
- • Consulted or admitted to GH Henri Mondor
- Exclusion Criteria:
- For pathological patients:
- • Refusal to participate by the patient (and/or legal representative in the case of minors)
- • Presence of schizophrenia, bipolar or anorexia nervosa
- For patients who are free of these conditions:
- • Presence of psychiatric or neurological pathology
- • Refusal to participate on the part of the patient (and/or on the part of the legal representative in the case of minors)
About Assistance Publique Hôpitaux De Paris
Assistance Publique - Hôpitaux de Paris (AP-HP) is a leading public hospital system in France, renowned for its commitment to healthcare excellence and innovative medical research. As a prominent clinical trial sponsor, AP-HP plays a pivotal role in advancing medical knowledge and improving patient care through rigorous scientific investigations across a wide range of therapeutic areas. With a focus on collaboration and interdisciplinary approaches, AP-HP leverages its extensive network of hospitals and expert clinicians to facilitate high-quality clinical trials that adhere to the highest ethical and regulatory standards, ultimately aiming to translate research findings into tangible health benefits for diverse patient populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Créteil, Creteil, France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported